Log in
Enquire now
‌

US Patent 9556274 Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies

Patent 9556274 was granted and assigned to Merrimack Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 9556274 Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.